ARTICLE | Distillery Therapeutics
Inhibitors of an orphan nuclear receptor for prostate cancer
May 29, 2020 6:36 PM UTC
INDICATION: Prostate cancer...
BCIQ Company Profiles
BCIQ Target Profiles
Nuclear receptor subfamily 2 group F member 2 (NR2F2) (COUP-TFII)